NOC vs TECH · P/E 17, rev $41.95B vs P/E 65, rev $1.22B
Northrop Grumman Corporation (NOC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NOC and TECH stock pages for the full models.
Not investment advice.